BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 11160674)

  • 41. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
    Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
    Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term observation of herpes simplex virus type 1 (HSV-1) infection in a child with Wiskott-Aldrich syndrome and a possible reactivation mechanism for thymidine kinase-negative HSV-1 in humans.
    Shiota T; Kurane I; Morikawa S; Saijo M
    Jpn J Infect Dis; 2011; 64(2):121-6. PubMed ID: 21519125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
    Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2.
    Sarisky RT; Nguyen TT; Duffy KE; Wittrock RJ; Leary JJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1524-9. PubMed ID: 10817703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
    Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
    Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
    Morfin F; Thouvenot D; Aymard M; Souillet G
    J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus.
    Chibo D; Druce J; Sasadeusz J; Birch C
    Antiviral Res; 2004 Feb; 61(2):83-91. PubMed ID: 14670581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected hep-2 cells.
    Baskin H; Yazici Z; Baskin Y; Olgun N; Ozkul A; Bahar IH
    New Microbiol; 2005 Jul; 28(3):205-13. PubMed ID: 16240692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa.
    Muller EE; Maseko DV; Kularatne RS
    Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Mechanism of Acyclovir Resistance in Herpes Simplex Virus 1, Which Has a UAG Stop Codon between the First and Second AUG Initiation Codons.
    Nguyen PHA; Yamada S; Shibamura M; Inagaki T; Fujii H; Harada S; Fukushi S; Mizuguchi M; Saijo M
    Jpn J Infect Dis; 2020 Nov; 73(6):447-451. PubMed ID: 32611982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
    Burrel S; Deback C; Agut H; Boutolleau D
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
    Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
    J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains.
    Kudo E; Shiota H; Naito T; Satake K; Itakura M
    J Med Virol; 1998 Oct; 56(2):151-8. PubMed ID: 9746072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study.
    Frobert E; Ooka T; Cortay JC; Lina B; Thouvenot D; Morfin F
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1055-9. PubMed ID: 15728902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.